Shu Tao
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 4
- Cancer Genomics and Diagnostics 3
-
- BRCA gene mutations in cancer 3
- Genetic Mapping and Diversity in Plants and Animals 3
-
- Colorectal Cancer Screening and Detection 3
-
- Wheat and Barley Genetics and Pathology 3
-
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Mao PangLimin RongChang LiuGuoliang SunXingchen KongZhenyu WangAili LiMeiling Jia
- Journals
- JNCI Journal of the National Cancer Institute (1 paper)Cancer (1 paper)Cancer Research (3 papers)
- Partner nations
- ChinaUnited StatesPoland
In The Last Decade
Shu Tao
46 papers receiving 790 citations
Peers
Comparison fields: 5 of 93
- Cancer Research 163
- Molecular Biology 456
- Genetics 159
- Oncology 121
- Plant Science 147
Countries citing papers authored by Shu Tao
This map shows the geographic impact of Shu Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Tao more than expected).
Fields of papers citing papers by Shu Tao
This network shows the impact of papers produced by Shu Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Tao. The network helps show where Shu Tao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shu Tao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 7 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 47 | |
| 11 | 2021 | 54 | |
| 12 | 2020 | 9 | |
| 13 | 2019 | 61 | |
| 14 | 2019 | 36 | |
| 15 | 2019 | 23 | |
| 16 | 2019 | 18 | |
| 17 | 2018 | 11 | |
| 18 | 2017 | 40 | |
| 19 | 2015 | 20 | |
| 20 | 2014 | 7 |
About Shu Tao
Shu Tao is a scholar working on Cancer Research, Aging and Molecular Biology, having authored 49 papers that have together received 793 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (4 papers), BRCA gene mutations in cancer (3 papers), Colorectal Cancer Screening and Detection (3 papers), Genetic Mapping and Diversity in Plants and Animals (3 papers), Cancer Genomics and Diagnostics (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Wheat and Barley Genetics and Pathology (3 papers). The work is most often cited by research in Cancer Research (163 citations), Molecular Biology (456 citations) and Genetics (159 citations). Shu Tao has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Mao Pang, Limin Rong, Chang Liu, Guoliang Sun, Xingchen Kong, Zhenyu Wang, Aili Li, Meiling Jia, Xiwei Wu and Shuaifeng Geng. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.